Core Viewpoint - Xinhua Medical (600587) has received the Medical Device Registration Certificate from the Shandong Provincial Drug Administration for its Thromboelastography Activated Coagulation Testing Kit, indicating a significant advancement in its product offerings in the medical device sector [1] Company Summary - The product, Thromboelastography Activated Coagulation Testing Kit, is designed for in vitro detection of coagulation function in human whole blood samples [1] - The kit is applicable for conditions such as coagulation dysfunction, acute trauma, and shock, assisting doctors in evaluating coagulation status and determining the efficacy of pro-coagulant and anticoagulant medications [1] - The registration certificate number is Lu Xie Zhao Zhun 20252400309, with an approval date of June 4, 2025, and a validity period until June 3, 2030 [1] Industry Summary - The approval of this medical device highlights the growing importance of advanced diagnostic tools in the healthcare industry, particularly in managing coagulation disorders and preventing thrombosis [1]